Previous close | 249.40 |
Open | 250.39 |
Bid | 250.85 x 900 |
Ask | 252.30 x 800 |
Day's range | 249.98 - 252.92 |
52-week range | 182.09 - 259.00 |
Volume | |
Avg. volume | 2,678,988 |
Market cap | 186.013B |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | 44.43 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.08 (0.43%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | N/A |
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 5, 2024 at 11:10 a.m. ET. The event will be simultaneously webcast on www.danaher.com.
Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) emission reduction targets in line with the Science Based Targets initiative (SBTi), including a long-term target to reach net-zero value chain emissions by no later than 2050. Danaher's pledge encompasses Scope 1, 2 and 3 GHG emissions and complements its existing commitment to reduce Scope 1 and 2 GHG emissions on an absolute basis by 50.4% by 2032 compared to 2021.
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on April 26, 2024 to holders of record on March 28, 2024.